Peptide therapy on TikTok: separating signal from hype

What did @iamcynthiagarcia actually say?

Garcia promoted GHK-Cu, which she called "GHQ CEO," as a copper peptide that declines with age and works on skin at a cellular level beyond what topical serums can reach. She uses it both topically and via injection, claims it "literally switches on the genes for cell regeneration," and recommends it around microneedling and laser procedures. She also pointed viewers toward her personal sourcing list via DM.

The core pitch: one peptide, visible results, 40 years of research, two delivery methods. That framing is more grounded than most peptide content on TikTok, but there are real problems with the injection claim and the sourcing angle that need unpacking.

Does the science back this up?

Partially, yes. GHK-Cu has a legitimate research record, though the human clinical data is thinner than Garcia implies. The "40 years of research" line is technically defensible. Loren Pickart first characterized GHK-Cu in the 1970s, and the compound has been studied extensively in cell culture and animal models.

On the gene regulation claim: Pickart and Margolina (2018, Cosmetics) published a review showing GHK-Cu modulates gene expression related to collagen synthesis, antioxidant response, and tissue remodeling in human dermal fibroblasts. That supports the "switches on genes for cell regeneration" framing, though calling it a literal switch oversimplifies transcriptional biology. On topical use, there is reasonable evidence. Leyden et al. (2017, Journal of Cosmetic Dermatology) found improvements in skin laxity and fine lines in a small randomized controlled trial with a GHK-Cu cream. The injection claim for "deeper cellular" effects is where the evidence gets thin. There are no published human trials on injectable GHK-Cu for cosmetic skin outcomes.

What did they get wrong (or right)?

Garcia got the basics right. GHK-Cu is a real compound, it does decline with age (serum levels drop from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60, per Pickart 1983), and topical evidence for skin texture and collagen support is credible. Credit where it is due.

What she got wrong or overstated:

• The name. She called it "GHQ CEO" repeatedly. The correct name is GHK-Cu (glycyl-L-histidyl-L-lysine copper). Small thing, but it matters for anyone trying to research it.
• The injection claim has no human clinical backing for cosmetic use. Injecting a peptide bypasses the skin entirely and introduces pharmacokinetics, dosing, sterility, and regulatory questions that a TikTok video cannot responsibly address.
• "40 years of research" is true in quantity but misleading in quality. Most studies are in vitro or animal models. Human RCT data is limited.
• Pointing followers to a private sourcing list is a red flag. Peptides sold for injection outside of a licensed clinical setting are not FDA-approved for this use and sourcing quality is genuinely variable.

What should you actually know?

GHK-Cu is one of the better-studied peptides in the cosmetic space, and topical products containing it are widely available and generally considered low-risk. If you want to try it, a reputable topical serum is a reasonable starting point with some evidence behind it.

The injection route is a different story. Injectable GHK-Cu is not FDA-approved. Any injectable peptide sourced outside a licensed compounding pharmacy with a valid prescription sits in a legal and safety gray zone. Contamination, incorrect dosing, and sterility failures are documented risks with unregulated peptide suppliers (Cohen et al., 2022, JAMA Internal Medicine reviewed harms from unregulated peptide use broadly).

The microneedling tip has some logic. Studies on wound healing suggest GHK-Cu applied to disrupted skin may support recovery, though this has not been tested in formal microneedling trials. Using a sterile, cosmetic-grade topical GHK-Cu product post-procedure is low risk. Injecting it is not the same conversation.

If you want GHK-Cu for skin, talk to a dermatologist or a licensed telehealth provider who can evaluate your actual skin concerns and recommend an evidence-appropriate approach, not a DM list.